Thoughts on COVID-19 and autoimmune diseases
10.1136/lupus-2020-000396
April 3, 2020
Most Read Articles
Could severe COVID-19 be considered a complementopathy?
10.1136/lupus-2020-000415
May 19, 2020
Interferon pathway in SLE: one key to unlocking the mystery of the disease
10.1136/lupus-2018-000270
August 13, 2019
Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
10.1136/lupus-2020-000395
May 19, 2020
Impact of COVID-19 pandemic on SLE: beyond the risk of infection
10.1136/lupus-2020-000408
May 5, 2020
Overcoming barriers to recruitment and retention of African–American women with SLE in behavioural interventions: lessons learnt from the WELL study
10.1136/lupus-2020-000391
June 11, 2020
Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus
10.1136/lupus-2020-000388
June 7, 2020
Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
10.1136/lupus-2019-000365
December 30, 2019
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
10.1136/lupus-2019-000375
June 15, 2020
Outcomes of pregnancy and associated factors in sub-Saharan African women with systemic lupus erythematosus: a scoping review
10.1136/lupus-2020-000400
June 14, 2020